Danimer Scientific
In David Einhorn's portfolio · Greenlight Capital
Ticker DNMR
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2024 | Sell | 0 | |
| Q3 2024 | Reduce 60% | 1,097,461 | 0.0% |
| Q2 2024 | No change | 2,734,580 | 0.1% |
| Q1 2024 | No change | 2,734,580 | 0.1% |
| Q4 2023 | Add 5% | 2,734,580 | 0.1% |
| Q3 2023 | Add 2% | 2,602,690 | 0.3% |
| Q2 2023 | No change | 2,550,000 | 0.3% |
| Q1 2023 | Add 13% | 2,550,000 | 0.5% |
| Q4 2022 | Add 17% | 2,250,000 | 0.3% |
| Q3 2022 | Add 134% | 1,924,940 | 0.4% |
| Q2 2022 | No change | 821,000 | 0.3% |
| Q1 2022 | No change | 821,000 | 0.3% |
| Q4 2021 | Reduce 65% | 821,000 | 0.4% |
| Q3 2021 | Add 12% | 2,358,172 | 2.6% |
| Q2 2021 | Reduce 2% | 2,108,172 | 3.3% |
| Q2 2021 | Sell | 0 | |
| Q1 2021 | Add 25% | 2,152,539 | 5.7% |
| Q1 2021 | Buy | 27,233 | 0.0% |
| Q4 2020 | Buy | 1,725,500 | 2.4% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.